• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一名患有与乳头状甲状腺癌相关的呼吸衰竭的儿科患者对乐伐替尼的反应]

[Response to lenvatinib in a pediatric patient with respiratory failure associated with papillary thyroid carcinoma].

作者信息

Dujovne Noelia, Lucero María B, Gazek Natalia, Pitoia Fabián, Felipe Laura, Ayarzabal Víctor, López Marti Jessica, Ciaccio Marta, Herzovich Viviana

机构信息

Servicio de Endocrinología, Hospital J. P. Garrahan.

Servicio de Neumonología, Hospital J. P. Garrahan.

出版信息

Arch Argent Pediatr. 2021 Feb;119(1):e70-e74. doi: 10.5546/aap.2021.e70.

DOI:10.5546/aap.2021.e70
PMID:33458996
Abstract

Papillary thyroid cancer is the most common thyroid tumor in childhood. In advanced stages, it can present with respiratory failure. The treatment of choice is total thyroidectomy and radioactive iodine. In cases of unresectable tumors, therapy with multikinase inhibitors should be considered. A 10-year-old girl was referred for progressive respiratory failure. A diagnosis of papillary thyroid cancer with pulmonary metastases was made. Due to the presence of an unresectable tumor not subject to surgery, the compassionate use of lenvatinib was indicated, showing a rapid and favorable clinical response with resolution of respiratory failure on the ninth day. Early diagnosis of papillary thyroid cancer prevents severe respiratory morbidity caused by late diagnoses. The use of lenvatinib should be considered as a previous step towards first-line therapies (surgery and radioactive iodine) in cases with great local and distant involvement.

摘要

乳头状甲状腺癌是儿童期最常见的甲状腺肿瘤。在晚期,它可表现为呼吸衰竭。首选治疗方法是全甲状腺切除术和放射性碘治疗。对于无法切除的肿瘤病例,应考虑使用多激酶抑制剂进行治疗。一名10岁女孩因进行性呼吸衰竭前来就诊。诊断为伴有肺转移的乳头状甲状腺癌。由于存在无法手术切除的肿瘤,因此建议同情使用乐伐替尼,结果显示临床反应迅速且良好,在第9天呼吸衰竭得到缓解。乳头状甲状腺癌的早期诊断可预防因诊断延迟导致的严重呼吸并发症。在局部和远处受累严重的病例中,应考虑将乐伐替尼的使用作为一线治疗(手术和放射性碘)的前期步骤。

相似文献

1
[Response to lenvatinib in a pediatric patient with respiratory failure associated with papillary thyroid carcinoma].[一名患有与乳头状甲状腺癌相关的呼吸衰竭的儿科患者对乐伐替尼的反应]
Arch Argent Pediatr. 2021 Feb;119(1):e70-e74. doi: 10.5546/aap.2021.e70.
2
Response to Lenvatinib in Children with Papillary Thyroid Carcinoma.儿童甲状腺乳头状癌患者对乐伐替尼的反应。
Thyroid. 2018 Nov;28(11):1450-1454. doi: 10.1089/thy.2018.0064. Epub 2018 Oct 16.
3
Lenvatinib complementary with radioiodine therapy for patients with advanced differentiated thyroid carcinoma: case reports and literature review.仑伐替尼联合放射性碘治疗晚期分化型甲状腺癌:病例报告及文献复习。
World J Surg Oncol. 2019 May 19;17(1):84. doi: 10.1186/s12957-019-1626-4.
4
Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.一名放射性碘难治性分化型甲状腺癌患者因严重蛋白尿对乐伐替尼不耐受,成功从乐伐替尼转换为索拉非尼治疗。
Auris Nasus Larynx. 2018 Dec;45(6):1249-1252. doi: 10.1016/j.anl.2018.05.003. Epub 2018 May 18.
5
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.索拉非尼治疗伴有弥漫性结节性肺病需要机械通气的儿童甲状腺癌患者的反应。
Thyroid. 2014 Jan;24(1):169-74. doi: 10.1089/thy.2012.0468. Epub 2013 Jul 25.
6
Lenvatinib: Role in thyroid cancer and other solid tumors.乐伐替尼:在甲状腺癌和其他实体肿瘤中的作用。
Cancer Treat Rev. 2016 Jan;42:47-55. doi: 10.1016/j.ctrv.2015.11.003. Epub 2015 Dec 2.
7
Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an Gene Mutation: A Case Study.仑伐替尼治疗伴有筛状-滤泡状变异型甲状腺乳头状癌和 基因突变患者的肺转移和结肠息肉:病例研究。
Thyroid. 2019 Oct;29(10):1511-1517. doi: 10.1089/thy.2019.0121. Epub 2019 Sep 25.
8
Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.索拉非尼治疗自闭症谱系障碍儿童伴弥漫性肺转移的甲状腺乳头状癌:病例报告。
BMC Cancer. 2017 Nov 21;17(1):775. doi: 10.1186/s12885-017-3782-7.
9
OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS.优化乐伐替尼治疗转移性放射性碘难治性分化型甲状腺癌患者的方案
Endocr Pract. 2017 Oct;23(10):1254-1261. doi: 10.4158/EP171822.OR. Epub 2017 Aug 17.
10
Long-term efficacy of lenvatinib for recurrent papillary thyroid carcinoma after multimodal treatment and management of complications: a case report.多模态治疗后复发性甲状腺乳头癌的仑伐替尼长期疗效及并发症处理:1 例报告
BMC Cancer. 2018 Jun 28;18(1):698. doi: 10.1186/s12885-018-4612-2.

引用本文的文献

1
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma.小儿分化型甲状腺癌的分子图谱与治疗策略
Endocr Rev. 2025 May 9;46(3):397-417. doi: 10.1210/endrev/bnaf003.
2
Long-term Treatment of Pediatric Metastatic Papillary Thyroid Cancer With Lenvatinib.乐伐替尼用于小儿转移性甲状腺乳头状癌的长期治疗
JCEM Case Rep. 2024 Jan 27;2(2):luad175. doi: 10.1210/jcemcr/luad175. eCollection 2024 Feb.